AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Meglisil 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Silicon Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Meglisil 2mg/500mg Tablet SR

Diabexe Duo 2mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use, even with controlled blood sugar, is crucial. Discontinuing without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The primary adverse effect is hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Meglisil 2mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Meglisil 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Meglisil 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Meglisil 2mg/500mg Extended-Release Tablet with food.

Common Side effects of Meglisil 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Meglisil 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Meglisil 2mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medicine with a meal.

How Meglisil 2mg/500mg Tablet SR works:

Meglisil SR tablets (2mg/500mg) combine glimepiride and metformin, two agents effective in diabetes management. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through decreased hepatic glucose production, reduced intestinal glucose uptake, and enhanced insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Meglisil 2mg/500mg SR tablets with alcohol is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Meglisil 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Meglisil tablets (2mg/500mg) are contraindicated for use while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Meglisil 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Meglisil 2mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Routine kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Meglisil 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. For those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in patients with severe liver dysfunction.

What if you forget to take Meglisil 2mg/500mg Tablet SR :

Should you forget to take your Meglisil 2mg/500mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Meglisil 2mg/500mg Tablet SR

LabelValue
Developing Good Habits No.
Type of Therapy Diabetes Management

FAQs on Meglisil 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Meglisil 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is particularly risky for patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Meglisil 2mg/500mg Tablet SR and seek immediate medical attention.
Meglisil 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Meglisil 2mg/500mg SR tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Meglisil 2mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Meglisil 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Meglisil 2mg/500mg SR tablets and alcohol is unsafe. Alcohol can exacerbate the drug's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Meglisil 2mg/500mg Tablet...
58
MRP 67
13% off